The mortality rate for pancreas malignant neoplasms in Germany is forecasted to increase steadily from 17.3 deaths per hundred thousand persons in 2024 to 17.7 in 2028. Comparing to 2023, which also stood at 17.3, the year-on-year increase is 0.58% per annum. The projected compound annual growth rate (CAGR) over the five-year period from 2024 to 2028 is approximately 0.58%.

Future trends to watch for:

Advances in early detection and treatment technologies which could significantly impact future mortality rates.
Policy changes aimed at healthcare improvement and prevention strategies for pancreatic cancer.
Demographic shifts, particularly in the aging population, which may influence these rates.